NCT06395155View on ClinicalTrials.gov

A Phase 1 Clinical Trial DHP2306R1 and DHP2306R2 in Healthy Adult Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

October 26, 2023

Primary Completion Date

December 7, 2023

Study Completion Date

December 7, 2023

Conditions
Musculoskeletal Pain
Interventions
DRUG

DHP2306R1

100mg per capsule, BID

DRUG

DHP2306R2

75mg per Tab, BID

Trial Locations (1)

Unknown

Chungbuk National University Hospital, Jungbuk

Sponsors
All Listed Sponsors
lead

Daehwa Pharmaceutical Co., Ltd.

INDUSTRY

NCT06395155 - A Phase 1 Clinical Trial DHP2306R1 and DHP2306R2 in Healthy Adult Volunteers | Biotech Hunter | Biotech Hunter